Works matching IS 13524585 AND DT 2021 AND VI 27 AND IP 6

Results: 23

Misdiagnosis of multiple sclerosis: Time for action.

Published in:

2021

By:

Brownlee, Wallace J;
Solomon, Andrew J

Publication type:

Editorial

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 864, doi. 10.1177/13524585211003476

By:

Achiron, Anat;
Dolev, Mark;
Menascu, Shay;
Zohar, Daniela-Noa;
Dreyer-Alster, Sapir;
Miron, Shmuel;
Shirbint, Emanuel;
Magalashvili, David;
Flechter, Shlomo;
Givon, Uri;
Guber, Diana;
Stern, Yael;
Polliack, Michael;
Falb, Rina;
Gurevich, Michael

Publication type:

Article

The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 913, doi. 10.1177/1352458520988148

By:

Midaglia, Luciana;
Sastre-Garriga, Jaume;
Pappolla, Agustín;
Quibus, Laura;
Carvajal, René;
Vidal-Jordana, Angela;
Arrambide, Georgina;
Río, Jordi;
Comabella, Manuel;
Nos, Carlos;
Castilló, Joaquin;
Galan, Ingrid;
Rodríguez-Acevedo, Breogan;
Auger, Cristina;
Tintoré, Mar;
Montalban, Xavier;
Rovira, Àlex

Publication type:

Article

COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence?

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 973, doi. 10.1177/1352458520949988

By:

Corrêa, Diogo Goulart;
de Souza Lima, Fabiana Cavalcanti;
da Cruz Bezerra, Daniel;
Coutinho Júnior, Antônio Carlos;
Hygino da Cruz Júnior, Luiz Celso

Publication type:

Article

Long-term course and morphological MRI correlates of cognitive function in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 954, doi. 10.1177/1352458520941474

By:

Pinter, Daniela;
Khalil, Michael;
Pirpamer, Lukas;
Damulina, Anna;
Pichler, Alexander;
Fruhwirth, Viktoria;
Ropele, Stefan;
Schmidt, Reinhold;
Fuchs, Siegrid;
Enzinger, Christian

Publication type:

Article

MRI findings in blinded trials should be available to treating physicians – Commentary.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 816, doi. 10.1177/13524585211003506

By:

Green, AJ

Publication type:

Article

Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 895, doi. 10.1177/1352458520940983

By:

Kassa, Roman M;
Sechi, Elia;
Flanagan, Eoin P;
Kaufmann, Timothy J;
Kantarci, Orhun H;
Weinshenker, Brian G;
Mandrekar, Jay;
Schmalstieg, William F;
Paz Soldan, M Mateo;
Keegan, B Mark

Publication type:

Article

MRI findings in blinded trials should be available to treating physicians – Yes.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 812, doi. 10.1177/1352458520984744

By:

Vukusic, Sandra;
Lebrun-Frenay, Christine

Publication type:

Article

MRI findings in blinded trials should be available to treating physicians – No.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 814, doi. 10.1177/1352458520986959

By:

Simmons, Sarah B;
Cohen, Jeffrey A

Publication type:

Article

Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseases.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 964, doi. 10.1177/1352458520948213

By:

Hyun, Jae-Won;
Lee, Hye Lim;
Jeong, Woo Kyo;
Lee, Hye Jung;
Shin, Jong Hwa;
Min, Ju-Hong;
Kim, Byoung Joon;
Kim, Seung Woo;
Shin, Ha Young;
Oh, Jeeyoung;
Kim, Woojun;
Shin, Hyun-June;
Oh, Sun-Young;
Kim, Hyunjin;
Lim, Young-Min;
Huh, So-Young;
Cho, Eun Bin;
Nam, Tai-Seung;
Lee, Seung-Han;
Kim, Sun-Young

Publication type:

Article

COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence? – Commentary.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 976, doi. 10.1177/1352458520958357

By:

Valencia-Sanchez, Cristina;
Flanagan, Eoin P

Publication type:

Article

Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 871, doi. 10.1177/1352458520939008

By:

Cai, Meng-Ting;
Zheng, Yang;
Shen, Chun-Hong;
Yang, Fan;
Fang, Wei;
Zhang, Yin-Xi;
Ding, Mei-Ping

Publication type:

Article

Measurement of white matter fiber-bundle cross-section in multiple sclerosis using diffusion-weighted imaging.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 818, doi. 10.1177/1352458520938999

By:

Storelli, Loredana;
Pagani, Elisabetta;
Preziosa, Paolo;
Filippi, Massimo;
Rocca, Maria A

Publication type:

Article

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 968, doi. 10.1177/1352458520943777

By:

Geraldes, Ruth;
Juryńczyk, Maciej;
dos Passos, Giordani Rodrigues;
Pichler, Alexander;
Chung, Karen;
Hagens, Marloes;
Ruggieri, Serena;
Auger, Cristina;
Sastre-Garriga, Jaume;
Enzinger, Christian;
Chard, Declan;
Barkhof, Frederik;
Gasperini, Claudio;
Rovira, Alex;
DeLuca, Gabriele;
Palace, Jacqueline

Publication type:

Article

Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 841, doi. 10.1177/1352458520941493

By:

Cacciaguerra, Laura;
Rocca, Maria A;
Storelli, Loredana;
Radaelli, Marta;
Filippi, Massimo

Publication type:

Article

Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 807, doi. 10.1177/1352458520928301

By:

Brown, Jordan;
Quattrochi, Blair;
Everett, Colleen;
Hong, Bo-Young;
Cervantes, Jorge

Publication type:

Article

Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 827, doi. 10.1177/1352458520940548

By:

Hidalgo de la Cruz, Milagros;
Valsasina, Paola;
Gobbi, Claudio;
Gallo, Antonio;
Zecca, Chiara;
Bisecco, Alvino;
Tedeschi, Gioacchino;
Filippi, Massimo;
Rocca, Maria A

Publication type:

Article

Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 903, doi. 10.1177/1352458520938354

By:

Croteau, David;
Tobenkin, Anne;
Brinker, Allen;
Kortepeter, Cindy M

Publication type:

Article

Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: A single-center experience.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 933, doi. 10.1177/1352458520936912

By:

Abbatemarco, Justin R;
Griffin, Austin;
Jones, Noble G;
Hartman, Jennifer;
McKee, Keith;
Wang, Zhini;
Nagel, Sean J;
Machado, Andre G;
Bethoux, Francois

Publication type:

Article

Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 883, doi. 10.1177/1352458520937282

By:

Longbrake, Erin E;
Mao-Draayer, Yang;
Cascione, Mark;
Zielinski, Tomasz;
Bame, Eris;
Brassat, David;
Chen, Chongshu;
Kapadia, Shivani;
Mendoza, Jason P;
Miller, Catherine;
Parks, Becky;
Xing, Diana;
Robertson, Derrick

Publication type:

Article

Visual field loss and structure–function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 855, doi. 10.1177/1352458520937281

By:

Deschamps, Romain;
Philibert, Manon;
Lamirel, Cedric;
Lambert, Jerome;
Vasseur, Vivien;
Gueguen, Antoine;
Bensa, Caroline;
Lecler, Augustin;
Marignier, Romain;
Vignal, Catherine;
Gout, Olivier

Publication type:

Article

Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG MS study.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 922, doi. 10.1177/1352458520936934

By:

Chitnis, Tanuja;
Banwell, Brenda;
Krupp, Lauren;
Arnold, Douglas L;
Bar-Or, Amit;
Brück, Wolfgang;
Giovannoni, Gavin;
Greenberg, Benjamin;
Ghezzi, Angelo;
Waubant, Emmanuelle;
Rostasy, Kevin;
Deiva, Kumaran;
Huppke, Peter;
Wolinsky, Jerry S;
Zhang, Ying;
Azmon, Amin;
K-Laflamme, Annik;
Karan, Rajesh;
Gärtner, Jutta

Publication type:

Article

Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue.

Published in:

Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 942, doi. 10.1177/1352458520936226

By:

Fitzgerald, Kathryn C;
Morris, Bridget;
Soroosh, Aurash;
Balshi, Alexandra;
Maher, Dermot;
Kaplin, Adam;
Nourbakhsh, Bardia

Publication type:

Article